Welcome to the international HTA database

Showing [23369 Records] Selected Records [0 Hits] [Clear]

Year	Source	Title
2017	Canary Health Service	[Development of shared decision support tools derived from clinical practice guideline recommendations]
2017	NIHR Health Technology Assessment programme	CollAborative care for Screen-Positive EldeRs with major depression (CASPER plus): a multicentred randomised controlled trial of clinical effectiveness and cost-effectiveness
2017	HAYES, Inc.	Propel and propel mini bioabsorbable steroid-releasing sinus implants for treatment of chronic rhinosinusitis in adults
2017	Institute for Clinical Effectiveness and Health Policy (IECS)	[CYD tetravalent dengue vaccine]
2017	NIHR Health Technology Assessment programme	Prevention and treatment of long-term social disability amongst young people with emerging severe mental illness with social recovery therapy (The PRODIGY Trial): study protocol for a randomised controlled trial
2017	HAYES, Inc.	EndoPredict (Myriad Genetics)
2017	Institute for Clinical Effectiveness and Health Policy (IECS)	[Ulipristal in uterine myomatosis]
2017	HAYES, Inc.	The prostate health index for prebiopsy triage (Beckman Coulter)
2017	Institute for Clinical Effectiveness and Health Policy (IECS)	[Platelet-rich plasma in diabetic foot ulcers]
2017	HAYES, Inc.	Adoptive immunotherapy using genetically modified lymphocytes for lymphoproliferative disorders or hematological malignancies
2017	Institute for Clinical Effectiveness and Health Policy (IECS)	[Lung cryobiopsy in diffuse interstitial lung disease diagnosis]
2017	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Cost-effective imaging for resectability of liver lesions in colorectal cancer: an economic decision model
2017	HAYES, Inc.	Cognitive rehabilitation therapy for traumatic brain injury (TBI)
2017	Institute for Clinical Effectiveness and Health Policy (IECS)	[Dual target deep brain stimulation in refractory dystonia]
2017	NIHR Health Technology Assessment programme	Cognitive-behaviour therapy for health anxiety in medical patients (CHAMP): a randomised controlled trial with outcomes to 5 years
2017	HAYES, Inc.	Comparative effectiveness of endovenous laser therapy versus conventional surgery for symptomatic varicose veins: a review of reviews
2017	Institute for Clinical Effectiveness and Health Policy (IECS)	[Lutetium-177 radiolabeled somatostatin analogs in neuroendocrine tumors]
2017	NIHR Health Technology Assessment programme	Spot protein-creatinine ratio and spot albumin-creatinine ratio in the assessment of pre-eclampsia: a diagnostic accuracy study with decision-analytic model-based economic evaluation and acceptability analysis
2017	HAYES, Inc.	Comparative effectiveness of Roux-en-Y gastric bypass and sleeve gastrectomy for treatment of type ii diabetes: a review of reviews
2017	Institute for Clinical Effectiveness and Health Policy (IECS)	[Platelet-rich plasma in orthopedic diseases]
2017	HAYES, Inc.	Comparative effectiveness review of cryoablation for primary treatment of localized prostate cancer
2017	Institute for Clinical Effectiveness and Health Policy (IECS)	[Platelet-rich plasma in maxillofacial surgery]
2017	HAYES, Inc.	Comparative effectiveness review of cryoablation for salvage treatment of recurrent prostate cancer following radiotherapy
2017	Basque Office for Health Technology Assessment (OSTEBA)	[Guide on Prader-Willi Syndrome. Guide to health personnel for the adequate knowledge and management of a rare disease called Prader-Willi Syndrome]
2017	Institute for Clinical Effectiveness and Health Policy (IECS)	[Induced sputum in severe asthma patients]
2017	NIHR Health Technology Assessment programme	Developing a multidisciplinary rehabilitation package following hip fracture and testing in a randomised feasibility study: Fracture in the Elderly Multidisciplinary Rehabilitation (FEMuR)
2017	HAYES, Inc.	Comparative effectiveness review of first-generation autologous chondrocyte implantation of the knee
2017	Basque Office for Health Technology Assessment (OSTEBA)	[Effectiveness of non-invasive mechanical ventilation for the treatment of respiratory failure in patients with amyotrophic lateral sclerosis]
2017	HAYES, Inc.	Comparative effectiveness review of paravertebral block for prevention of chronic pain after breast surgery
2017	Basque Office for Health Technology Assessment (OSTEBA)	[Online hemodiafiltration: evaluation of its safety, effectiveness, cost and usage indications]
2017	NIHR Health Technology Assessment programme	Start2quit: a randomised clinical controlled trial to evaluate the effectiveness and cost-effectiveness of using personal tailored risk information and taster sessions to increase the uptake of the NHS Stop Smoking Services
2017	HAYES, Inc.	Comparative effectiveness review of robotically assisted hysterectomy
2017	Basque Office for Health Technology Assessment (OSTEBA)	[ATOMs – Adjustable Transobturator Male System. Device for urinary incontinence]
2017	Agency for Healthcare Research and Quality (AHRQ)	Supplemental project to assess the transparency of reporting requirements for studies evaluating the effectiveness of treatment options for symptoms of diabetic peripheral neuropathy
2017	HAYES, Inc.	Comparative effectiveness review of second- and third-generation autologous chondrocyte implantation of the knee
2017	Basque Office for Health Technology Assessment (OSTEBA)	[Endoscopic mucosal resection (EMR) and endoscopic mucosal dissection (EMD) in superficial gastrointestinal tumors]
2017	HAYES, Inc.	Comparative effectiveness review of single-level artificial disc replacement for cervical degenerative disc disease
2017	Basque Office for Health Technology Assessment (OSTEBA)	[Analysis of the efficacy, safety and efficiency of stabilisation of intervertebral discs using Discogel]
2017	Canadian Agency for Drugs and Technologies in Health (CADTH)	Treatments for locally advanced oropharyngeal cancer: a systematic review of clinical effectiveness and cost-effectiveness
2017	HAYES, Inc.	Comparative effectiveness review of topical antiseptic products for antisepsis prior to vascular or epidural catheter insertion
2017	Basque Office for Health Technology Assessment (OSTEBA)	[Clinical effectiveness and cost-effectiveness of non-invasive telemonitoring on patients with heart failure]
2017	HAYES, Inc.	Comparative effectiveness review of topical chlorhexidine gluconate for preoperative skin antisepsis
2017	Basque Office for Health Technology Assessment (OSTEBA)	[Evaluation of the utility and indication of prostate biopsies with image fusion – magnetic resonance and transrectal ultrasound]
2017	Health Quality Ontario (HQO)	Percutaneous ventricular assist devices: a health technology assessment
2017	HAYES, Inc.	Fecal calprotectin assay for monitoring disease activity in Crohn disease
2017	Basque Office for Health Technology Assessment (OSTEBA)	[Updating of the shared work system for systematic reviews of the evidence and critical appraisal (FLC 3.0 Platform)]
2017	NIHR Health Technology Assessment programme	Real-time modelling of a pandemic influenza outbreak
2017	Health Quality Ontario (HQO)	Patient safety learning systems: a systematic review and qualitative synthesis
2017	HAYES, Inc.	Local injection therapy for cervicogenic headache and occipital neuralgia
2017	Basque Office for Health Technology Assessment (OSTEBA)	[System for percutaneous replacement of mitral valve (MitraClip). Monitoring Study Protocol (1st part)]
2017	Health Quality Ontario (HQO)	Pharmacogenomic testing for psychotropic medication selection: a systematic review of the Assurex GeneSight Psychotropic test
2017	HAYES, Inc.	Positron emission tomography-computed tomography (PET-CT) for detection of primary site in neuroendocrine tumors of unknown origin
2017	Basque Office for Health Technology Assessment (OSTEBA)	[System for percutaneous replacement of mitral valve using a Clip. Monitoring study (part 2)]
2017	Canadian Agency for Drugs and Technologies in Health (CADTH)	Dual antiplatelet therapy following percutaneous coronary intervention: a review of the clinical impact of treatment duration
2017	HAYES, Inc.	The clinical utility of lumbar discography for assessing low back pain: impact on patient management and health outcomes
2017	Canadian Agency for Drugs and Technologies in Health (CADTH)	Proton beam therapy for the treatment of cancer in children and adults: a health technology assessment
2017	NIHR Health Technology Assessment programme	A randomised controlled trial to compare the safety, effectiveness and cost effectiveness of doxycycline (200 mg/day) with oral prednisolone (0.5 mg/kg/day) for initial treatment of bullous pemphigoid: the Bullous Pemphigoid Steroids and Tetracyclines (BLISTER) Trial
2017	NIHR Health Technology Assessment programme	A cluster randomised trial, cost-effectiveness analysis and psychosocial evaluation of insulin pump therapy compared with multiple injections during flexible intensive insulin therapy for type 1 diabetes: the REPOSE Trial
2017	HAYES, Inc.	Transcatheter closure of prosthetic aortic or mitral paravalvular leaks
2017	Canadian Agency for Drugs and Technologies in Health (CADTH)	New drugs for type 2 diabetes: second-line therapy - science report
2017	Agency for Healthcare Research and Quality (AHRQ)	Glasgow Coma Scale for field triage of trauma: a systematic review
2017	HAYES, Inc.	Wireless capsule systems for diagnosis of gastroparesis and monitoring of gastrointestinal motility
2017	Agency for Healthcare Research and Quality (AHRQ)	Tonsillectomy for obstructive sleep-disordered breathing or recurrent throat infection in children
2017	NIHR Health Services and Delivery Research programme	Cross-national mixed-methods comparative case study of recovery-focused mental health care planning and co-ordination in acute inpatient mental health settings (COCAPP-A)
2017	Agency for Healthcare Research and Quality (AHRQ)	First- and second-generation antipsychotics in children and young adults: systematic review update
2017	NIHR Health Services and Delivery Research programme	Investigating the organisational factors associated with variation in clinical productivity in community pharmacies: a mixed-methods study
2017	Canadian Agency for Drugs and Technologies in Health (CADTH)	Dialysis modalities for the treatment of end-stage kidney disease: a health technology assessment
2017	German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI)	[Care needs assessment tools]
2017	Agency for Healthcare Research and Quality (AHRQ)	Interventions to prevent age-related cognitive decline, mild cognitive impairment, and clinical Alzheimer's-type dementia
2017	NIHR Health Services and Delivery Research programme	Quality and reporting standards, resources, training materials and information for realist evaluation: the RAMESES II project
2017	Agency for Healthcare Research and Quality (AHRQ)	Preventing complications and treating symptoms of diabetic peripheral neuropathy
2017	NIHR Health Services and Delivery Research programme	Optimal NHS service delivery to care homes: a realist evaluation of the features and mechanisms that support effective working for the continuing care of older people in residential settings
2017	NIHR Health Technology Assessment programme	Randomised controlled trial and economic analysis of an internet-based weight management programme: POWeR+ (Positive Online Weight Reduction)
2017	Agency for Healthcare Research and Quality (AHRQ)	Assessment tools for palliative care
2017	NIHR Health Services and Delivery Research programme	Variations in mortality across the week following emergency admission to hospital: linked retrospective observational analyses of hospital episode data in England, 2004/5 to 2013/14
2017	Agency for Healthcare Research and Quality (AHRQ)	Treatment of osteoarthritis of the knee: an update review
2017	NIHR Public Health Research (PHR) programme	Assessing the impact and cost-effectiveness of needle/syringe provision and opiate substitution therapy on hepatitis C transmission among people who inject drugs in the United Kingdom: analysis of pooled datasets and economic modelling
2017	NIHR Health Technology Assessment programme	Timing of surgical intervention for developmental dysplasia of the hip: a randomised controlled trial (Hip 'Op)
2017	Agency for Healthcare Research and Quality (AHRQ)	Tympanostomy tubes in children with otitis media
2017	NIHR Public Health Research (PHR) programme	Adapting the ASSIST model of informal peer-led intervention delivery to the Talk to FRANK drug prevention programme in UK secondary schools (ASSIST + FRANK): intervention development, refinement and a pilot cluster randomised controlled trial
2017	NIHR Public Health Research (PHR) programme	Results of the First Steps study: a randomised controlled trial and economic evaluation of the Group Family Nurse Partnership (gFNP) programme compared with usual care in improving outcomes for high-risk mothers and their children and preventing abuse
2017	NIHR Health Technology Assessment programme	CollAborative care and active surveillance for Screen-Positive EldeRs with subthreshold depression (CASPER): a multicentred randomised controlled trial of clinical effectiveness and cost-effectiveness
2017	NIHR Public Health Research (PHR) programme	Could scale-up of parenting programmes improve child disruptive behaviour and reduce social inequalities? Using individual participant data meta-analysis to establish for whom programmes are effective and cost-effective
2017	National Institute for Health and Care Excellence (NICE)	Pomalidomide for multiple myeloma previously treated with lenalidomide and bortezomib. NICE technology appraisal guidance 427
2017	NIHR Health Technology Assessment programme	Accessibility and implementation in the UK NHS services of an effective depression relapse prevention programme: learning from mindfulness-based cognitive therapy through a mixed-methods study
2017	National Institute for Health and Care Excellence (NICE)	Pembrolizumab for treating PD-L1-positive non-small-cell lung cancer after chemotherapy. NICE technology appraisal guidance 428
2017	National Institute for Health and Care Excellence (NICE)	Ibrutinib for previously treated chronic lymphocytic leukaemia and untreated chronic lymphocytic leukaemia with 17p deletion or TP53 mutation. NICE technology appraisal guidance 429
2017	Belgian Health Care Knowledge Centre (KCE)	Bevacizumab in the treatment of ovarian cancer
2017	National Institute for Health and Care Excellence (NICE)	Sofosbuvir-velpatasvir for treating chronic hepatitis C. NICE technology appraisal guidance 430
2017	National Institute for Health and Care Excellence (NICE)	Everolimus for advanced renal cell carcinoma after previous treatment. NICE technology appraisal guidance 432
2017	National Institute for Health and Care Excellence (NICE)	Apremilast for treating active psoriatic arthritis. NICE technology appraisal guidance 433
2016	NIHR Health Technology Assessment programme	Psychoeducation with problem-solving (PEPS) therapy for adults with personality disorder: a pragmatic randomised controlled trial to determine the clinical effectiveness and cost-effectiveness of a manualised intervention to improve social functioning
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Andexanet alfa for acute major bleeding episodes requiring reversal of anticoagulation, including reversal of factor Xa inhibition – first line
2016	Institut national d'excellence en sante et en services sociaux (INESSS)	[Impact evaluation of optimal use guidelines implementation for self-monitoring of blood glucose by adult patients with type 2 diabetes and not using insulin]
2016	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Blinatumomab - Assessment according to §35a (para. 1., sentence 10) Social Code Book V]
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Intrathecal idursulfase (Elaprase) for Hunter syndrome (mucopolysaccharidosis type II)
2016	Institut national d'excellence en sante et en services sociaux (INESSS)	[Guides for the pharmacological treatment of STBBIs]
2016	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Carfilzomib - Assessment according to §35a (para. 1., sentence 10) Social Code Book V]
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Nusinersen for paediatric-onset spinal muscular atrophy – first line
2016	Institut national d'excellence en sante et en services sociaux (INESSS)	[Extracorporeal photopheresis: main indications and implementation parameters]